In CRC, the results of Li et al showed that the DFS and OS of the higher KRT80 expression patient group were much worse than those of the lower KRT80 expression group, and KRT80 expression was an independent prognostic factor for poor DFS and OS of CRC patients based on a log‐rank test of 120 CRC patients; however, Wu et al found that KRT80 expression was not significantly associated with clinical outcomes of CRC patients in a survival analysis of 466 samples in the TCGA‐CRC dataset. Here, KRT80 is linked to colorectal carcinoma.